An observational study in Metabolic Syndrome and Schizophrenia, sponsored by Seoul National Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2009-06-12.
Sponsored by Seoul National Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 53 studies in Metabolic Syndrome with a site in Korea, Republic of — 4 open to participants now, 4 under way, none of them phase 3. Metabolic Syndrome · Korea, Republic of.
Among the 53 studies in Metabolic Syndrome with a site in Korea, Republic of, this one is the 6th largest by planned enrollment of the 22 observational ones that give a count, is one of 5 that started in 2007, is one of 22 observational ones, and was the 4th registered.
2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.
Browse Metabolic Syndrome studies →4 of the 53 studies in Metabolic Syndrome with a site in Korea, Republic of are open now. Recruiting first, the newest first:
JW Pharmaceutical · Sites in Korea, Republic of
Ages 19+
Korea University Anam Hospital · Sites in Korea, Republic of
Ages 19+
Samsung Medical Center · Sites in Korea, Republic of
Ages 40+
Hallym University · Sites in Korea, Republic of
Ages 20–70
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 5 started in 2007.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,000 is above the median of 196 across 497 observational studies indexed under Metabolic Syndrome.
Median enrollment 67 across the 31 interventional studies, 150 across the 22 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 53 have an industry lead sponsor. The 10 most frequent:
Seoul National Hospital is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Seoul National Hospital has 3 studies filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Metabolic Syndrome with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07523971JW PharmaceuticalEfficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 53 studies in Metabolic Syndrome with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to assess the cross-sectional prevalence of the metabolic syndrome in patients with schizophrenia taking antipsychotics.
Schizophrenic patients taking any kind of antipsychotics for at least 1 year at the Seoul National Hospital will be participated in this study.
we are planning to enroll approximately 1000 patients with schizophrenia.
For each subject
we will calculate the rates of patients who meet the criteria for the Metabolic syndrome.
2 or more of followings
DSM-IV diagnosis of schizophrenia
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
inpatients and outpatients in Seoul National Hospital
metabolic syndrome
Time frame: cross-sectional
each factor of metabolic syndrome
The record gives a start of Dec 2007 and a completion of Sep 2009. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jun 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National Hospital